Catalyst Funds Management’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,365
Closed -$105K 1414
2024
Q1
$105K Buy
+2,365
New +$105K 0.03% 383